Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dihydroergotamine mesylate
Drug ID BADD_D00672
Description A 9,10alpha-dihydro derivative of [ergotamine]. Dihydroergotamine is used as an abortive therapy for migraines.[L38469] Its use has largely been supplanted by triptans in current therapy due to the class's greater selectivity and more favourable side effect profile. Recent improvements have been made in the design of intranasal delivery devices allowing for greater delivery of dihydroergotamine solution to the vasculature-rich upper nasal cavity.[A239569] The recently approved Precision Olfactory Delivery technology developed by Impel Neuropharma technology has correlated with an increase of 3-fold in Cmax and 4-fold in AUC despite the solution formulated at 75% of the strength of the existing intranasal product.
Indications and Usage Dihydroergotamine (DHE) in all formulations is indicated for the acute treatment of migraine with or without aura in adults.[L38459, L38464, L38469] As an injection, DHE is also indicated for the acute treatment of cluster headache episodes.[L38459] DHE is not indicated for migraine prevention or the management of hemiplegic or basilar migraine.[L38459, L38464, L38469]
Marketing Status approved; investigational
ATC Code N02CA01
DrugBank ID DB00320
KEGG ID D02211
MeSH ID D004087
PubChem ID 71171
TTD Drug ID D0V3ZA
NDC Product Code 0143-9273; 62778-336; 55486-1599; 68682-357; 0574-0850; 47848-006; 51927-0295; 38779-0303; 55486-1587; 49452-2616; 62991-2858; 61990-0411; 77530-725; 81284-411; 51927-1706; 24201-463; 0187-0245; 72888-096; 17337-0061; 25021-609; 0143-9151; 70529-030
UNII 81AXN7R2QT
Synonyms Dihydroergotamine | Clavigrenin | D-Tamin Retard L.U.T. | D Tamin Retard L.U.T. | DET MS | DHE-45 | DHE 45 | DHE45 | D.H.E. 45 | DHE-Puren | DHE Puren | DHE-Ratiopharm | DHE Ratiopharm | Dihydroergotamin AL | Dihydroergotamine Mesylate | Mesylate, Dihydroergotamine | Dihydroergotamine Methanesulfonate | Methanesulfonate, Dihydroergotamine | Dihytamin | Erganton | Ergomimet | Ergont | Ergotam Von Ct | Von Ct, Ergotam | Ikaran | Migranal | Dihydergot | Dihydroergotamine-Sandoz | Dihydroergotamine Sandoz | Orstanorm | Seglor | Agit | Tamik | Verladyn | Angionorm
Chemical Information
Molecular Formula C34H41N5O8S
CAS Registry Number 6190-39-2
SMILES CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N (C5)C.CS(=O)(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anxiety19.06.02.002--
Arteriospasm coronary12.02.01.031; 24.04.04.005; 02.02.02.005--Not Available
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Diarrhoea07.02.01.001--
Dizziness24.06.02.007; 17.02.05.003; 02.11.04.006--
Dyspnoea02.11.05.003; 22.02.01.004--
Fibrosis08.03.01.001--Not Available
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Headache17.14.01.001--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypertension24.08.02.001--
Myocardial infarction24.04.04.009; 02.02.02.007--
Myocardial ischaemia24.04.04.010; 02.02.02.008--Not Available
Paraesthesia17.02.06.005; 23.03.03.094--
Pleural fibrosis22.05.03.003--Not Available
Rash23.03.13.001--Not Available
Retroperitoneal fibrosis10.02.01.026; 20.06.01.006; 07.07.03.003--Not Available
Vasospasm24.04.02.002--Not Available
Ventricular fibrillation02.03.04.008--
Ventricular tachycardia02.03.04.010--
The 1th Page    1    Total 1 Pages